ABI-007 (nanoparticle paclitaxel)

paclitaxel nanoparticle formulation · Celgene Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABI-007 (nanoparticle paclitaxel), covering 2012-03-08 to 2012-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis [Phase 1, Phase 2]